Navigation section

Medicamen Biotech Limited

Medicamen Biotech Limited

Performance

Today's Low Today's High
441.60 441.15
473.70 468.10
52 Week Low 52 Week High
355.45 (13-Mar-2024) 356.75 (13-Mar-2024)
729.60 (30-Oct-2023) 765.00 (28-Sep-2023)
Open
468.25 464.75
Previous Close
463.15 462.40
Volume
0.35
Total Traded value
1.58 (₹ Lakhs)
Upper circuit
554.55 687.65
Lower circuit
369.75 458.45

Market Depth

Buy Order Quantity Sell Order Quantity
44
 0
Bid PriceQuantity
446.9544.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:44
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Fundamentals

Market Cap: ₹5.73 Cr
PE Ratio (TTM): 52.78
PB Ratio: 2.81
Industry P/E:92.80
Debt to Equity:-
ROE:5.32
EPS (TTM):8.76
Book Value:159.06
Face Value: 10.00

Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue42.67 Cr40.50 Cr37.15 Cr34.12 Cr33.53 Cr
Profit3.01 Cr4.42 Cr4.05 Cr3.76 Cr3.61 Cr
Expense39.22 Cr35.73 Cr32.85 Cr30.53 Cr29.91 Cr
Comprehensive income3.01 Cr4.42 Cr4.05 Cr3.76 Cr3.61 Cr
EPS2.383.493.252.972.85
Medicamen Biotech Limited is a pharmaceutical company based in New Delhi, India. Established in 1993, the company is involved in extensive research, development, manufacturing, marketing, sales, and distribution of pharmaceutical formulations and APIs within India. Their diverse product portfolio includes tablets, both non-beta lactam and beta lactam capsules, liquid and dry syrups, ointments, creams, as well as oral solid and liquid products. These products cater to various therapeutic areas such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited is committed to providing high-quality healthcare solutions to meet the needs of patients across India.
Company nameListing dateIndustry NSE symbol BSE symbol
Medicamen Biotech Limited Oct, 2021 Oct, 1995 Pharmaceuticals Pharmaceuticals MEDICAMEQ MEDICAMEQ

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

  • Promoters 
    		 43.21%
    Public 
    		 56.79%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.21%
    Public 
    		 56.79%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.21%
    Public 
    		 56.79%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.21%
    Public 
    		 56.79%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.21%
    Public 
    		 56.79%
    Shares held by Employee Trusts 
    		 0.00%

Medicamen Biotech Limited FAQ's

What is the range of today's stock performance for Medicamen Biotech Limited?

Today's stock performance witnessed a fluctuation from a minimum of 441.60 on the NSE (National Stock Exchange) to a maximum of 473.70. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 441.15 to a high of 468.10.

What are the 52-week low and high values for Medicamen Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 355.45 (occurred on 13-Mar-2024) and a high of 729.60 (achieved on 30-Oct-2023) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 356.75 (on 13-Mar-2024), and the 52-week high is 765.00 (on 28-Sep-2023).

What was the opening and previous closing prices for Medicamen Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 355.45 (occurred on 13-Mar-2024) and a high of 729.60 (achieved on 30-Oct-2023) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 356.75 (on 13-Mar-2024), and the 52-week high is 765.00 (on 28-Sep-2023).

What is the total volume and traded value for Medicamen Biotech Limited for the day?

The total volume is 0, and the total traded value is 1.58 (₹ Lakhs).

What are the upper and lower circuit limits for Medicamen Biotech Limited?

The upper circuit limit is 554.55, and the lower circuit limit is 369.75.

What is the market cap and PE ratio for Medicamen Biotech Limited?

The market cap is ₹5.73 Cr, and the PE ratio (TTM) is 92.80.

What is the PB ratio, industry P/E, and debt to equity ratio for Medicamen Biotech Limited?

The PB ratio is 2.84, industry P/E is 92.80 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Medicamen Biotech Limited?

ROE is 5.32, EPS is 8.76, book value is 159.06

What are the revenue and profit figures for the latest quarter and previous quarters for Medicamen Biotech Limited?

In Sep 2023, Revenue is ₹426710000.00, and Profit is ₹30120000.00. In Jun 2023, Revenue is ₹405034000.00, and Profit is ₹44170000.00.

When was Medicamen Biotech Limited listed, and what industry does it belong to?

The company, Medicamen Biotech Limited, was listed in Oct 2021 and belongs to the Pharmaceuticals industry. Its NSE symbol is MEDICAMEQ.

What is the current shareholding pattern of the Medicamen Biotech Limited?

As of latest available update, promoters hold 43.21%, the public holds 56.79%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
2083
Threads
33
Settings

Latest Business News

Share this stock

Back
Top